(n-3) long-chain PUFA differentially affect resistance to Pseudomonas aeruginosa infection of male and female cftr-/- Mice

Journal of Nutrition

Volumn 141, Issue 6, 2011, Pages 1101-1107

  Tiesset, Hélène ^a   Bernard, Henry ^a   Bartke, Nana ^b   Beermann, Christopher ^c   Flachaire, Elisabeth ^d   Desseyn, Jean Luc ^a   Gottrand, Frédéric ^a   Husson, Marie Odile ^a  

^a UNIVERSITÉ DE LILLE   (France)

^b Danone Research   (Germany)

^c University of Applied Science Fulda   (Germany)

^d Hôpital Renée Sabran   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DOCOSAHEXAENOIC ACID; ICOSAPENTAENOIC ACID; INTERLEUKIN 6; KERATINOCYTE DERIVED CHEMOKINE; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; TRANSMEMBRANE CONDUCTANCE REGULATOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL LOAD; CELL MEMBRANE; CELL MEMBRANE PERMEABILITY; CONTROLLED STUDY; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR MOUSE; DIET SUPPLEMENTATION; DIETARY INTAKE; DISEASE PREDISPOSITION; DRUG EFFICACY; FEMALE; GENDER; LUNG; LUNG INFECTION; LUNG INJURY; MALE; MOUSE; NEUTROPHIL; NEUTROPHIL COUNT; NONHUMAN; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTION; TREATMENT DURATION; TREATMENT OUTCOME; WEIGHT GAIN; WILD TYPE;

ANIMALS; BRONCHOALVEOLAR LAVAGE FLUID; CYSTIC FIBROSIS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; CYTOKINES; DIETARY SUPPLEMENTS; DISEASE SUSCEPTIBILITY; FATTY ACIDS, OMEGA-3; FEMALE; HUMANS; INFLAMMATION MEDIATORS; LUNG; MALE; MICE; MICE, 129 STRAIN; MICE, INBRED C57BL; MICE, INBRED CFTR; MICE, KNOCKOUT; OPPORTUNISTIC INFECTIONS; PNEUMONIA, BACTERIAL; PSEUDOMONAS INFECTIONS; SEX FACTORS;

BACTERIA (MICROORGANISMS); MUS; PSEUDOMONAS AERUGINOSA;

EID: 79958221506     PISSN: 00223166     EISSN: 15416100     Source Type: Journal    
DOI: 10.3945/jn.110.134585     Document Type: Article

References (64)

1. Perez-Vilar J, Boucher RC. Reevaluating gel-forming mucins' roles in cystic fibrosis lung disease. Free Radic Biol Med. 2004;37:1564-77.
2. Hartl D, Latzin P, Hordijk P, Marcos V, Rudolph C, Woischnik M, Krauss-Etschmann S, Koller B, Reinhardt D, et al. Cleavage of CXCR1 on neutrophils disables bacterial killing in cystic fibrosis lung disease. Nat Med. 2007;13:1423-30.
3. Tager AM, Wu J, Vermeulen MW. The effect of chloride concentration on human neutrophil functions: potential relevance to cystic fibrosis. Am J Respir Cell ol Biol. 1998;19:643-52.
4. Tirouvanziam R, Gernez Y, Conrad CK, Moss RB, Schrijver I, Dunn CE, Davies ZA, Herzenberg LA, Herzenberg LA. Profound functional and signaling changes in viable inflammatory neutrophils homing to cystic fibrosis airways. Proc Natl Acad Sci USA. 2008;105:4335-9.
5. Watt AP, Courtney J, Moore J, Ennis M, Elborn JS. Neutrophil cell death, activation and bacterial infection in cystic fibrosis. Thorax. 2005; 60:659-64.
6. Becker MN, Sauer MS,Muhlebach MS, Hirsh AJ,Wu Q, VergheseMW, Randell SH. Cytokine secretion by cystic fibrosis airway epithelial cells. Am J espir Crit Care Med. 2004;169:645-53.
7. Bruscia EM, Zhang PX, Ferreira E, Caputo C, Emerson JW, Tuck D, Krause DS, Egan ME. Macrophages directly contribute to the exaggerated inflammatory response in cystic fibrosis transmembrane conductance regulator-/- mice. Am J Respir Cell Mol Biol. 2009; 40:295-304.
8. Courtney JM, Ennis M, Elborn JS. Cytokines and inflammatory mediators in cystic fibrosis. J Cyst Fibros. 2004;3:223-31.
9. Khan TZ,Wagener JS, Bost T, Martinez J, Accurso FJ, Riches DW. Early pulmonary inflammation in infants with cystic fibrosis. Am J Respir Crit Care Med. 995;151:1075-82.
10. Muhlebach MS, Stewart PW, Leigh MW, Noah TL. Quantitation of inflammatory responses to bacteria in young cystic fibrosis and control patients. Am J espir Crit Care Med. 1999;160:186-91.
11. DiMango E, Ratner AJ, Bryan R, Tabibi S, Prince A. Activation of NFkappaB by adherent Pseudomonas aeruginosa in normal and cystic fibrosis respiratory pithelial cells. J Clin Invest. 1998;101:2598-605.
12. Joseph T, Look D, Ferkol T. NF-kappaB activation and sustained IL-8 gene expression in primary cultures of cystic fibrosis airway epithelial cells stimulated with Pseudomonas aeruginosa. Am J Physiol Lung Cell Mol Physiol. 2005;288:L471-9.
13. Venkatakrishnan A, Stecenko AA, King G, Blackwell TR, Brigham KL, Christman JW, Blackwell TS. Exaggerated activation of nuclear factorkappaB and altered IkappaB-beta processing in cystic fibrosis bronchial epithelial cells. Am J Respir Cell Mol Biol. 2000;23:396-403.
14. Weber AJ, Soong G, Bryan R, Saba S, Prince A. Activation of NFkappaB in airway epithelial cells is dependent on CFTR trafficking and Cl- channel function. Am J Physiol Lung Cell Mol Physiol. 2001;281: L71-8.
15. Carpagnano GE, Barnes PJ, Geddes DM, Hodson ME, Kharitonov SA. Increased leukotriene B4 and interleukin-6 in exhaled breath condensate in cystic ibrosis. Am J Respir Crit Care Med. 2003; 167:1109-12.
16. Craig-Schmidt MC, Faircloth SA, Weete JD. Modulation of avian lung eicosanoids by dietary omega-3 fatty acids. J Nutr. 1987;117:1197-206.
17. Steger B, Colvin HP. Eicosanoids in cystic fibrosis. N Engl J Med. 2004;350:2000-1.
18. Craig-Schmidt MC, Faircloth SA, Teer PA, Weete JD, Wu CY. The essential fatty acid deficient chicken as a model for cystic fibrosis. Am J Clin Nutr. 986;44:816-24.
19. Gilljam H, Strandvik B, Ellin A, Wiman LG. Increased mole fraction of arachidonic acid in bronchial phospholipids in patients with cystic fibrosis. Scand J Clin ab Invest. 1986;46:511-8.
20. Bhura-Bandali FN, Suh M, Man SF, Clandinin MT. The deltaF508 mutation in the cystic fibrosis transmembrane conductance regulator alters control of essential fatty acid utilization in epithelial cells. J Nutr. 2000;130:2870-5.
21. Ollero M, Laposata M, Zaman MM, Blanco PG, Andersson C, Zeind J, Urman Y, Kent G, Alvarez JG, et al. Evidence of increased flux to n-6 docosapentaenoic acid in phospholipids of pancreas from cftr-/- knockout mice. Metabolism. 2006;55:1192-200.
22. Roulet M, Frascarolo P, Rappaz I, Pilet M. Essential fatty acid deficiency in well nourished young cystic fibrosis patients. Eur J Pediatr. 1997;156:952-6.
23. Thompson GN. Relationships between essential fatty acid levels, pulmonary function and fat absorption in pre-adolescent cystic fibrosis children with good linical scores. Eur J Pediatr. 1989;148:327-9.
24. Strandvik B, Gronowitz E, Enlund F, Martinsson T, Wahlstrom J. Essential fatty acid deficiency in relation to genotype in patients with cystic fibrosis. J ediatr. 2001;139:650-5.
25. Van Biervliet S, Vanbillemont G, Van Biervliet JP, Declercq D, Robberecht E, Christophe A. Relation between fatty acid composition and clinical status or genotype in cystic fibrosis patients. Ann Nutr Metab. 2007;51:541-9.
26. Lloyd-Still JD. Essential fatty acid deficiency and nutritional supplementation in cystic fibrosis. J Pediatr. 2002;141:157-9.
27. Auvin S, Collet F, Gottrand F, Husson MO, Leroy X, Beermann C, Guery BP. Long-chain polyunsaturated fatty acids modulate lung inflammatory response induced by Pseudomonas aeruginosa in mice. Pediatr Res. 2005;58:211-5.
28. Pierre M, Husson MO, Le BR, Desseyn JL, Galabert C, Beghin L, Beermann C, Dagenais A, Berthiaume Y, et al. Omega-3 polyunsaturated fatty acids improve host response in chronic Pseudomonas aeruginosa lung infection in mice. Am J Physiol Lung Cell Mol Physiol. 2007;292:L1422-31.
29. Tetaert D, Pierre M, Demeyer D, Husson MO, Beghin L, Galabert C, Gottrand F, Beermann C, Guery B, et al. Dietary n-3 fatty acids have suppressive effects on mucin upregulation in mice infected with Pseudomonas aeruginosa. Respir Res. 2007;8:39.
30. Tiesset H, Pierre M, Desseyn JL, Guery B, Beermann C, Galabert C, Gottrand F, Husson MO. Dietary (n-3) polyunsaturated fatty acids affect the kinetics of pro- and antiinflammatory responses in mice with Pseudomonas aeruginosa lung infection. J Nutr. 2009;139:82-9.
31. Guilbault C, Saeed Z, Downey GP, Radzioch D. Cystic fibrosis mouse models. Am J Respir Cell Mol Biol. 2007;36:1-7.
32. Rosenfeld M, Davis R, FitzSimmons S, Pepe M, Ramsey B. Gender gap in cystic fibrosis mortality. Am J Epidemiol. 1997;145:794-803.
33. Coste TC, Deumer G, Reychler G, Lebecque P, Wallemacq P, Leal T. Influence of pancreatic status and sex on polyunsaturated fatty acid profiles in cystic ibrosis. Clin Chem. 2008;54:388-95.
34. Snouwaert JN, Brigman KK, Latour AM, Malouf NN, Boucher RC, Smithies O, Koller BH. An animal model for cystic fibrosis made by gene targeting. cience. 1992;257:1083-8.
35. Reeves PG, Nielsen FH, Fahey GC Jr. AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. J Nutr. 1993;123:1939-51.
36. Verbeke G, Molenberghs G. Linear mixed models for longitudinal data. New York: Springer; 2000.
37. Conover WJ, Iman RL. Rank transformations as a bridge between parametric and nonparametric statistics. The American Statistician. 1981;35:124-9.
38. van Heeckeren AM, Schluchter MD, Xue W, Davis PB. Response to acute lung infection with mucoid Pseudomonas aeruginosa in cystic fibrosis mice. Am J espir Crit Care Med. 2006;173:288-96.
39. McMorran BJ, Palmer JS, Lunn DP, Oceandy D, Costelloe EO, Thomas GR, Hume DA, Wainwright BJ. G551D CF mice display an abnormal host response and have impaired clearance of Pseudomonas lung disease. Am J Physiol Lung Cell Mol Physiol. 2001;281: L740-7.
40. van Heeckeren AM, Schluchter M, Xue L, Alvarez J, Freedman S, St GJ, Davis PB. Nutritional effects on host response to lung infections with mucoid seudomonas aeruginosa in mice. Infect Immun. 2004;72:1479-86.
41. Saadane A, Soltys J, Berger M. Role of IL-10 deficiency in excessive nuclear factor-kappaB activation and lung inflammation in cystic fibrosis transmembrane conductance regulator knockout mice. J Allergy Clin Immunol. 2005;115:405-11.
42. Guilbault C, Martin P, Houle D, Boghdady ML, Guiot MC, Marion D, Radzioch D. Cystic fibrosis lung disease following infection with Pseudomonas aeruginosa in Cftr knockout mice using novel non-invasive direct pulmonary infection technique. Lab Anim. 2005;39:336-52.
43. Coakley RD, Sun H, Clunes LA, Rasmussen JE, Stackhouse JR, Okada SF, Fricks I, Young SL, Tarran R. 17beta-Estradiol inhibits Ca2+-dependent homeostasis of airway surface liquid volume in human cystic fibrosis airway epithelia. J Clin Invest. 2008;118:4025-35.
44. Caputo A, Caci E, Ferrera L, Pedemonte N, Barsanti C, Sondo E, Pfeffer U, Ravazzolo R, Zegarra-Moran O, et al. TMEM16A, a membrane protein associated with calcium-dependent chloride channel activity. Science. 2008;322:590-4.
45. Yang YD, Cho H, Koo JY, Tak MH, Cho Y, Shim WS, Park SP, Lee J, Lee B, et al. TMEM16A confers receptor-activated calcium-dependent chloride onductance. Nature. 2008;455:1210-5.
46. Freedman SD, Katz MH, Parker EM, Laposata M, Urman MY, Alvarez JG. A membrane lipid imbalance plays a role in the phenotypic expression of cystic fibrosis in cftr(-/-) mice. Proc Natl Acad Sci USA. 1999;96:13995-4000.
47. Dombrowsky H, Clark GT, Rau GA, Bernhard W, Postle AD. Molecular species compositions of lung and pancreas phospholipids in the cftr(tm1HGU/tm1HGU) cystic fibrosis mouse. Pediatr Res. 2003;53: 447-54.
48. Freedman SD, Blanco PG, Zaman MM, Shea JC, Ollero M, Hopper IK, Weed DA, Gelrud A, Regan MM, et al. Association of cystic fibrosis with abnormalities in fatty acid metabolism. N Engl J Med. 2004; 350:560-9.
49. Davidson DJ, Rolfe M. Mouse models of cystic fibrosis. Trends Genet. 2001;17:S29-37.
50. Al-Turkmani MR, Freedman SD, Laposata M. Fatty acid alterations and n-3 fatty acid supplementation in cystic fibrosis. Prostaglandins Leukot Essent Fatty cids. 2007;77:309-18.
51. Kitson AP, Stroud CK, Stark KD. Elevated production of docosahexaenoic acid in females: potential molecular mechanisms. Lipids. 2010; 45:209-24.
52. Calder PC. n-3 polyunsaturated fatty acids, inflammation, and inflammatory diseases. Am J Clin Nutr. 2006;83:S1505-19.
53. Serhan CN. Novel chemical mediators in the resolution of inflammation: resolvins and protectins. Anesthesiol Clin. 2006;24:341-64.
54. Serhan CN, Lu Y, Hong S, Yang R. Mediator lipidomics: search algorithms for eicosanoids, resolvins, and protectins. Methods Enzymol. 2007;432:275-17.
55. Serhan CN, Chiang N, Van Dyke TE. Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators. Nat Rev Immunol. 2008;8:349-61.
56. Endres S, Ghorbani R, Kelley VE, Georgilis K, Lonnemann G, van der Meer JW, Cannon JG, Rogers TS, Klempner MS, et al. The effect of dietary supplementation with n-3 polyunsaturated fatty acids on the synthesis of interleukin-1 and tumor necrosis factor by mononuclear cells. N Engl J Med. 1989;320:265-1.
57. Lee TH, Hoover RL, Williams JD, Sperling RI, Ravalese J III, Spur BW, Robinson DR, Corey EJ, Lewis RA, et al. Effect of dietary enrichment with eicosapentaenoic and docosahexaenoic acids on in vitro neutrophil and monocyte leukotriene generation and neutrophil function. N Engl J Med. 1985;312:1217-24.
58. Sperling RI, Benincaso AI, Knoell CT, Larkin JK, Austen KF, Robinson DR. Dietary omega-3 polyunsaturated fatty acids inhibit phosphoinositide formation nd chemotaxis in neutrophils. J Clin Invest. 1993; 91:651-60.
59. Chambrier C, Bastard JP, Rieusset J, Chevillotte E, Bonnefont-Rousselot D, Therond P, Hainque B, Riou JP, Laville M, et al. Eicosapentaenoic acid induces mRNA expression of peroxisome proliferator-activated receptor gamma. Obes Res. 2002;10:518-25.
60. Ricote M, Glass CK. PPARs and molecularmechanisms of transrepression. Biochim Biophys Acta. 2007;1771:926-35.
61. Morise A, Thomas C, Landrier JF, Besnard P, Hermier D. Hepatic lipid metabolism response to dietary fatty acids is differently modulated by PPARalpha in ale and female mice. Eur J Nutr. 2009; 48:465-73.
62. Crisafulli C, Bruscoli S, Esposito E, Mazzon E, Di PR, Genovese T, Bramanti P, Migliorati G, Cuzzocrea S. PPAR-alpha contributes to the anti-inflammatory activity of 17beta-estradiol. J Pharmacol Exp Ther. 2009;331:796-807.
63. Freedman SD, Weinstein D, Blanco PG, Martinez-Clark P, Urman S, Zaman M, Morrow JD, Alvarez JG. Characterization of LPS-induced lung inflammation in cftr2/2 mice and the effect of docosahexaenoic acid. J Appl Physiol. 2002;92:2169-76.
64. Keen C, Olin AC, Eriksson S, Ekman A, Lindblad A, Basu S, Beermann C, Strandvik B. Supplementation with Fatty acids influences the airway nitric oxide and inflammatory markers in patients with cystic fibrosis. J Pediatr Gastroenterol Nutr. 2010;50:537-44.